ENGOT_ov50-INNOVATE-3

Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz) concomitant with weekly paclitaxel for the treatment of platinum-resistant ovarian cancer (PROC)

Coordinating investigator

Prof. Dr. med.
Viola A.
Heinzelmann-Schwarz
Universitätsspital Basel
+41 61 265 90 99

For further information on the trial, please consult the ENGOT website

Clinics

All trials